In a new review published by American Thinker, writer James Anthony frames Dr. Mary Talley Bowden โ a Stanford-trained ear, nose, and throat specialist who became one of the most visible physicians challenging COVID-era treatment protocols โ as a quiet, stubborn figure who turned personal conviction into a sprawling legal and political fight. The piece, dated September 18, 2026, is nominally a review of Bowden’s book Dangerous Misinformation, but it reads at least as much as a tribute to the author herself.
Anthony opens by recalling the early, disorienting days of the pandemic, when he and his wife watched the MedCram video series and absorbed early discussions about vitamin D, hydroxychloroquine and zinc, ivermectin and zinc, NAC, prone positioning, and steroids. He says he expected government officials to lean on their authority by dismissing off-label treatments. What he didn’t anticipate, he writes, was the breadth of the resistance โ not just from elected officials and agencies, but from pharmaceutical companies, hospitalists, most clinical practitioners, chain pharmacy managers, and most pharmacists.
From direct-pay practice to the center of a storm
Bowden’s path to prominence, as Anthony tells it, began relatively small. After raising four children, she returned to medicine by launching a direct-pay practice in 2019, which gave her patient-level experience with what he describes as a hands-on learning curve. According to the review, her book presents itself as a straightforward narrative but actually spans a striking range of subjects โ and Anthony encourages readers to step back from the “close combat” detail occasionally to appreciate the larger arc of her career.

He notes that early in her residency, Bowden prescribed the antibiotic trovafloxacin for chronic sinusitis, a drug later withdrawn over serious liver injuries, and that she prescribed proton-pump inhibitors for throat tightness on an ongoing basis โ a class of drugs that has since drawn long-term safety questions. When she opened her own practice, the review says, she revisited and changed those habits.
Then came COVID. Anthony traces what he characterizes as an escalating series of doors closing. Bowden began by offering rapid PCR tests and publicly posting weekly positivity rates. She moved to breathing treatments administered in patients’ cars, then to hydroxychloroquine and azithromycin, until hydroxychloroquine prescribing was limited. She pivoted to monoclonal antibodies, but supply โ in his account โ was throttled and the emergency use authorization later revoked. Finally, she turned to ivermectin, and Anthony writes that “all hell broke loose.”
Cancellation, litigation, and the Musk-era reprieve
The review is scathing about the institutional response. Anthony writes that hospitals “imprisoned patients,” restricted treatments he says clinicians were demonstrating to be effective, and imposed what he calls harmful treatments. He also asserts that social media platforms were government-funded in their efforts to attack independent physicians like Bowden. According to his account, Bowden was initially canceled on social media and reported to her medical board, as were many other clinicians.

What follows, in Anthony’s telling, is a sequence of countermoves. When injuries from COVID vaccines began to appear, Bowden started treating those patients as well. A turning point came when Elon Musk acquired Twitter and reinstated her account โ and, at her request, the accounts of twelve other physicians in similar situations, according to the review. Bowden sued the FDA over a tweet that Anthony says denigrated anyone who had used ivermectin for COVID, and she won. She backed politicians who supported health freedom. She broke with MAHA, Anthony writes, when its focus shifted toward foods, toxic chemicals, and over-medicalization of children while, in his characterization, going quiet on mRNA vaccines. And she took on the large Houston hospital systems, the Texas Medical Board, and the Federation of State Medical Boards, which he describes as nominally non-governmental but highly influential.
What the reviewer is really praising
Anthony is careful to note that his admiration isn’t purely about energy or combativeness. He writes that Bowden uses compact space to pack in dense factual material on both medical and political questions, showing fluency in physiology as well as in institutional and social dynamics. But what impresses him most, he says, is her judgment and emotional intelligence โ her ability to identify what he calls the “core tyrants” of a scientifically sophisticated modern world riddled with old crony relationships, and to direct her fight at them rather than at softer targets.
His closing argument is broader than one physician’s story. Dangerous Misinformation, he writes, illustrates what happens when someone from a profession with formidable skills runs up against the modern administrative state โ spread across nominally private bodies like the Federation of State Medical Boards and crony companies in pharma โ and is thrust into life-and-death conflicts on behalf of patients and families. Bowden, he concludes, fought back resolutely and on multiple fronts, remarkably effectively throughout.
The review lands in a continuing national argument over how the COVID response will be judged: whether figures like Bowden were dangerous outliers or early dissenters whose treatments and warnings deserved a fairer hearing. Anthony leaves no ambiguity about where he stands. “Bowden speaks softly, and supposedly controversially,” he writes. “But the natural introvert Bowden is a heroine in action.”
Source: www.americanthinker.com โ https://www.americanthinker.com/blog/2026/09/a-covid-hero-speaks/
